Postural Orthostatic Tachycardia Syndrome in COVID-19: A Contemporary Review of Mechanisms, Clinical Course and Management

References

• Olshansky B, Cannom D, Fedorowski A, et al. Postural Orthostatic Tachycardia Syndrome (POTS): a critical assessment. Prog Cardiovasc Dis. 2020;63(3):263–270. doi:10.1016/j.pcad.2020.03.010
   PubMed Web of Science ®Google Scholar
• Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology. 1993;43(1 Part 1):132. doi:10.1212/WNL.43.1_Part_1.132
   PubMed Web of Science ®Google Scholar
• WHO coronavirus (COVID-19) dashboard; 2023. Available from: https://covid19.who.int. Accessed May 10, 2023.
   Google Scholar
• Sheldon RS, Grubb BP, Olshansky B, et al. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12(6):e41–63. doi:10.1016/j.hrthm.2015.03.029
   PubMed Web of Science ®Google Scholar
• Raj SR, Arnold AC, Barboi A, et al. Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clin Auton Res. 2021;31(3):365–368. doi:10.1007/s10286-021-00798-2
   PubMed Web of Science ®Google Scholar
• Arnold AC, Ng J, Raj SR. Postural tachycardia syndrome - diagnosis, physiology, and prognosis. Auton Neurosci Basic Clin. 2018;215:3–11. doi:10.1016/j.autneu.2018.02.005
   PubMed Web of Science ®Google Scholar
• Low PA, Sandroni P, Joyner M, Shen WK. Postural Tachycardia Syndrome (POTS). J Cardiovasc Electrophysiol. 2009;20(3):352–358. doi:10.1111/j.1540-8167.2008.01407.x
   PubMed Web of Science ®Google Scholar
• McDonald C, Koshi S, Busner L, Kavi L, Newton JL. Postural tachycardia syndrome is associated with significant symptoms and functional impairment predominantly affecting young women: a UK perspective. BMJ Open. 2014;4(6):e004127. doi:10.1136/bmjopen-2013-004127
   PubMed Web of Science ®Google Scholar
• Lei LY, Chew DS, Sheldon RS, Raj SR. Evaluating and managing postural tachycardia syndrome. Cleve Clin J Med. 2019;86(5):333–344. doi:10.3949/ccjm.86a.18002
   PubMed Web of Science ®Google Scholar
• Thieben MJ, Sandroni P, Sletten DM, et al. Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo Clin Proc. 2007;82(3):308–313. doi:10.1016/S0025-6196(11)61027-6
   PubMed Web of Science ®Google Scholar
• Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. 2000;343(12):847–855. doi:10.1056/NEJM200009213431204
   PubMed Web of Science ®Google Scholar
• PubMed. Autoimmune basis for postural tachycardia syndrome; 2022. Available from: https://pubmed.ncbi.nlm.nih.gov/24572257/. Accessed May 10, 2023.
   Google Scholar
• Peggs KJ, Nguyen H, Enayat D, Keller NR, Al-Hendy A, Raj SR. Gynecologic disorders and menstrual cycle lightheadedness in postural tachycardia syndrome. Int J Gynaecol Obstet. 2012;118(3):242–246. doi:10.1016/j.ijgo.2012.04.014
   PubMed Web of Science ®Google Scholar
• Sandroni P, Opfer-Gehrking TL, McPhee BR, Low PA. Postural tachycardia syndrome: clinical features and follow-up study. Mayo Clin Proc. 1999;74(11):1106–1110. doi:10.4065/74.11.1106
   PubMed Web of Science ®Google Scholar
• Watari M, Nakane S, Mukaino A, et al. Autoimmune postural orthostatic tachycardia syndrome. Ann Clin Transl Neurol. 2018;5(4):486–492. doi:10.1002/acn3.524
   PubMed Web of Science ®Google Scholar
• Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. 2021;69(2):205–211. doi:10.1007/s12026-021-09185-5
   PubMed Web of Science ®Google Scholar
• Wang LB, Culbertson CJ, Deb A, Morgenshtern K, Huang H, Hohler AD. Gastrointestinal dysfunction in postural tachycardia syndrome. J Neurol Sci. 2015;359(1–2):193–196. doi:10.1016/j.jns.2015.10.052
   PubMed Web of Science ®Google Scholar
• Deb A, Morgenshtern K, Culbertson CJ, Wang LB, Hohler AD. A survey-based analysis of symptoms in patients with postural orthostatic tachycardia syndrome. Proc Bayl Univ Med Cent. 2015;28(2):157–159. doi:10.1080/08998280.2015.11929217
   PubMedGoogle Scholar
• Shaw BH, Stiles LE, Bourne K, et al. The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey. J Intern Med. 2019;286(4):438–448. doi:10.1111/joim.12895
   PubMed Web of Science ®Google Scholar
• BlogAdmin. Cognitive dysfunction and “Brain Fog” in POTS | the dysautonomia dispatch; 2022. Available from: https://dysautonomiainternational.org/blog/wordpress/cognitive-dysfunction-and-brain-fog-in-pots/. Accessed May 10, 2023.
   Google Scholar
• Miglis MG, Barwick F. Sleep disorders in patients with postural tachycardia syndrome: a review of the literature and guide for clinicians. Auton Neurosci Basic Clin. 2018;215:62–69. doi:10.1016/j.autneu.2018.05.002
   PubMed Web of Science ®Google Scholar
• Raj SR, Guzman JC, Harvey P, et al. Canadian Cardiovascular Society position statement on Postural Orthostatic Tachycardia Syndrome (POTS) and related disorders of chronic orthostatic intolerance. Can J Cardiol. 2020;36(3):357–372. doi:10.1016/j.cjca.2019.12.024
   PubMed Web of Science ®Google Scholar
• NICE. Overview | COVID-19 rapid guideline: managing the long-term effects of COVID-19 | guidance. NICE; 2020. Available from: https://www.nice.org.uk/guidance/ng188. Accessed May 10, 2023.
   Google Scholar
• Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023. Available from https://www.nature.com/articles/s41579-022-00846-2.
   Web of Science ®Google Scholar
• Zubchenko S, Kril I, Nadizhko O, Matsyura O, Chopyak V. Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study. Rheumatol Int. 2022;42(9):1523–1530. doi:10.1007/s00296-022-05146-9
   PubMed Web of Science ®Google Scholar
• Peluso MJ, Deveau TM, Munter SE, et al. Impact of pre-existing chronic viral infection and reactivation on the development of long COVID. J Clin Invest. 2022. Available from https://www.jci.org/articles/view/163669.
   Google Scholar
• Swank Z, Senussi Y, Manickas-Hill Z, et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. 2022;14:ciac722.
   Google Scholar
• Wang EY, Mao T, Klein J, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595(7866):283–288. doi:10.1038/s41586-021-03631-y
   PubMed Web of Science ®Google Scholar
• Li H, Yu X, Liles C, et al. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc Cardiovasc Cerebrovasc Dis. 2014;3(1):e000755. doi:10.1161/JAHA.113.000755
   PubMed Web of Science ®Google Scholar
• Gunning WT, Kvale H, Kramer PM, Karabin BL, Grubb BP. Postural orthostatic tachycardia syndrome is associated with elevated G-protein coupled receptor autoantibodies. J Am Heart Assoc. 2019;8(18):e013602. doi:10.1161/JAHA.119.013602
   PubMed Web of Science ®Google Scholar
• Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - part 1. Auton Neurosci. 2021;235:102828. doi:10.1016/j.autneu.2021.102828
   PubMed Web of Science ®Google Scholar
• Jara LJ, Vera-Lastra O, Mahroum N, Pineda C, Shoenfeld Y. Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand? Clin Rheumatol. 2022;41(5):1603–1609. doi:10.1007/s10067-022-06149-4
   PubMed Web of Science ®Google Scholar
• Ormiston CK, Świątkiewicz I, Taub PR. Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart Rhythm. 2022;19(11):1880–1889. doi:10.1016/j.hrthm.2022.07.014
   PubMed Web of Science ®Google Scholar
• Kwan AC, Ebinger JE, Wei J, et al. Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 Infection. Nat Cardiovasc Res. 2022;1(12):1187–1194. doi:10.1038/s44161-022-00177-8
   PubMedGoogle Scholar
• Skufca J, Ollgren J, Ruokokoski E, Lyytikäinen O, Nohynek H. Incidence rates of Guillain Barré (GBS), chronic fatigue/systemic exertion intolerance disease (CFS/SEID) and postural orthostatic tachycardia syndrome (POTS) prior to introduction of human papilloma virus (HPV) vaccination among adolescent girls in Finland, 2002–2012. Papillomavirus Res Amst Neth. 2017;3:91–96.
   PubMedGoogle Scholar
• Blitshteyn S, Brinth L, Hendrickson JE, Martinez-Lavin M. Autonomic dysfunction and HPV immunization: an overview. Immunol Res. 2018;66(6):744–754. doi:10.1007/s12026-018-9036-1
   PubMed Web of Science ®Google Scholar
• Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn DI, Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res. 2020;2020:1–3.
   Google Scholar
• Reddy S, Reddy S, Arora M. A case of postural orthostatic tachycardia syndrome secondary to the messenger RNA COVID-19 vaccine. Cureus. 2021;13(5):e14837. doi:10.7759/cureus.14837
   PubMed Web of Science ®Google Scholar
• Park J, Kim S, Lee J, An JY. A case of transient POTS following COVID-19 vaccine. Acta Neurol Belg. 2022;122(4):1081–1083. doi:10.1007/s13760-022-02002-2
   PubMed Web of Science ®Google Scholar
• Umapathi T, Poh MQW, Fan BE, Li KFC, George J, Tan JYL. Acute hyperhidrosis and postural tachycardia in a COVID-19 patient. Clin Auton Res. 2020;30(6):571–573. doi:10.1007/s10286-020-00733-x
   PubMed Web of Science ®Google Scholar
• Rudofker EW, Parker H, Cornwell WK. An exercise prescription as a novel management strategy for treatment of long COVID. JACC Case Rep. 2022;4(20):1344–1347. doi:10.1016/j.jaccas.2022.06.026
   PubMedGoogle Scholar
• Shouman K, Vanichkachorn G, Cheshire WP, et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021;31(3):385–394. doi:10.1007/s10286-021-00803-8
   PubMed Web of Science ®Google Scholar
• Desai AD, Boursiquot BC, Moore CJ, et al. Autonomic dysfunction post-acute COVID-19 infection. Hear Case Rep. 2022;8(3):143–146.
   PubMedGoogle Scholar
• Agnihotri SP, Luis CVS, Kazamel M. Autonomic neuropathy as post-acute sequela of SARS-CoV-2 infection: a case report. J Neurovirol. 2022;28(1):158–161. doi:10.1007/s13365-022-01056-5
   PubMed Web of Science ®Google Scholar
• Ocher RA, Padilla E, Hsu JC, Taub PR. Clinical and laboratory improvement in hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 infection. Case Rep Cardiol. 2021;2021:7809231. doi:10.1155/2021/7809231
   PubMed Web of Science ®Google Scholar
• Parker WH, Moudgil R, Wilson RG, Tonelli AR, Mayuga KA, Singh TK. COVID-19 and postural tachycardia syndrome: a case series. Eur Heart J Case Rep. 2021;5(12):ytab325. doi:10.1093/ehjcr/ytab325
   PubMedGoogle Scholar
• Hermel M, Sweeney M, Abud E, et al. COVID-19 vaccination might induce postural orthostatic tachycardia syndrome: a case report. Vaccines. 2022;10(7):991. doi:10.3390/vaccines10070991
   Web of Science ®Google Scholar
• O’Sullivan JS, Lyne A, Vaughan CJ. COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine. BMJ Case Rep. 2021;14(6):e243585. doi:10.1136/bcr-2021-243585
   PubMedGoogle Scholar
• Jamal SM, Landers DB, Hollenberg SM, et al. Prospective evaluation of autonomic dysfunction in post-acute sequela of COVID-19. J Am Coll Cardiol. 2022;79(23):2325–2330. doi:10.1016/j.jacc.2022.03.357
   PubMed Web of Science ®Google Scholar
• Kitsou V, Blomberg B, Lunde T, Saeed S. Intermittent left bundle branch block with septal flash and postural orthostatic tachycardia syndrome in a young woman with long COVID-19. BMJ Case Rep. 2022;15(6):e249608. doi:10.1136/bcr-2022-249608
   PubMedGoogle Scholar
• Johansson M, Ståhlberg M, Runold M, et al. Long-haul post–COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. JACC Case Rep. 2021;3(4):573–580. doi:10.1016/j.jaccas.2021.01.009
   PubMedGoogle Scholar
• Varanasi S, Sathyamoorthy M, Chamakura S, Shah SA. Management of long-COVID postural orthostatic tachycardia syndrome with enhanced external counterpulsation. Cureus. 2021;13(9):e18398. doi:10.7759/cureus.18398
   PubMed Web of Science ®Google Scholar
• Kanjwal K, Jamal S, Kichloo A, Grubb B. New-onset postural orthostatic tachycardia syndrome following coronavirus disease 2019 infection. J Innov Card Rhythm Manag. 2020;11(11):4302–4304. doi:10.19102/icrm.2020.111102
   PubMedGoogle Scholar
• Rao P, Peritz DC, Systrom D, Lewine K, Cornwell WK, Hsu JJ. Orthostatic and exercise intolerance in recreational and competitive athletes with long COVID. JACC Case Rep. 2022;4(17):1119–1123. doi:10.1016/j.jaccas.2022.07.007
   PubMedGoogle Scholar
• Sanada Y, Azuma J, Hirano Y, Hasegawa Y, Yamamoto T. Overlapping myocarditis and postural orthostatic tachycardia syndrome after COVID-19 messenger RNA vaccination: a case report. Cureus. 2022;14(11):e31006. doi:10.7759/cureus.31006
   PubMed Web of Science ®Google Scholar
• Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn DI, Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res. 2020;30(5):449–451. doi:10.1007/s10286-020-00727-9
   PubMed Web of Science ®Google Scholar
• Ishibashi Y, Yoneyama K, Tsuchida T, Akashi Y. Post-COVID-19 postural orthostatic tachycardia syndrome. Intern Med. 2021;60(14):2345. doi:10.2169/internalmedicine.7626-21
   PubMed Web of Science ®Google Scholar
• Kalia R, Kalia R, Musih J, Cubelo M, Popat J. Post-COVID-19 syndrome: a novel diagnosis. Cureus. 2022;14(8):e28266. doi:10.7759/cureus.28266
   PubMed Web of Science ®Google Scholar
• Bosco J, Titano R. Severe post-COVID-19 dysautonomia: a case report. BMC Infect Dis. 2022;22(1):214. doi:10.1186/s12879-022-07181-0
   PubMed Web of Science ®Google Scholar
• Garland EM, Raj SR, Black BK, Harris PA, Robertson D. The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome. Neurology. 2007;69(8):790–798. doi:10.1212/01.wnl.0000267663.05398.40
   PubMed Web of Science ®Google Scholar
• Ståhlberg M, Reistam U, Fedorowski A, et al. Post-COVID-19 tachycardia syndrome: a distinct phenotype of post-acute COVID-19 syndrome. Am J Med. 2021;134(12):1451–1456. doi:10.1016/j.amjmed.2021.07.004
   PubMedGoogle Scholar
• Raj SR, Fedorowski A, Sheldon RS. Diagnosis and management of postural orthostatic tachycardia syndrome. Can Med Assoc J. 2022;194(10):E378–85. doi:10.1503/cmaj.211373
   Web of Science ®Google Scholar
• Raj SR. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management - Fedorowski - 2019. J Intern Med. 2022. doi:10.1111/joim.12852
   Google Scholar
• Raj SR, Biaggioni I, Yamhure PC, et al.Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation. 2023. doi:10.1161/01.cir.0000160356.97313.5d
   Google Scholar
• Narasimhan B, Aggarwal D, Satish P, Kantharia B, Aronow WS. Postural orthostatic tachycardia syndrome: pathophysiology, management, and experimental therapies. Expert Opin Investig Drugs. 2022;31(10):1017–1025. doi:10.1080/13543784.2022.2121697
   PubMed Web of Science ®Google Scholar
• Shibata S, Fu Q, Bivens TB, Hastings JL, Wang W, Levine BD. Short-term exercise training improves the cardiovascular response to exercise in the postural orthostatic tachycardia syndrome. J Physiol. 2012;590(15):3495–3505. doi:10.1113/jphysiol.2012.233858
   PubMed Web of Science ®Google Scholar
• Fu Q, Levine BD. Exercise and non-pharmacological treatment of POTS. Auton Neurosci Basic Clin. 2018;215:20–27. doi:10.1016/j.autneu.2018.07.001
   PubMed Web of Science ®Google Scholar
• Fu Q, VanGundy TB, Shibata S, Auchus RJ, Williams GH, Levine BD. Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome. Hypertension. 2011;58(2):167–175. doi:10.1161/HYPERTENSIONAHA.111.172262
   PubMed Web of Science ®Google Scholar
• Tahir F, Bin Arif T, Majid Z, Ahmed J, Khalid M. Ivabradine in postural orthostatic tachycardia syndrome: a review of the literature. Cureus. 2020;12(4):e7868. doi:10.7759/cureus.7868
   PubMed Web of Science ®Google Scholar
• Gee ME, Watkins AK, Brown JN, Young EJA. Ivabradine for the treatment of postural orthostatic tachycardia syndrome: a systematic review. Am J Cardiovasc Drugs. 2018;18(3):195–204. doi:10.1007/s40256-017-0252-1
   PubMed Web of Science ®Google Scholar
• Kanjwal K, Karabin B, Sheikh M, et al. Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience. Pacing Clin Electrophysiol. 2011;34(6):750–755. doi:10.1111/j.1540-8159.2011.03047.x
   PubMed Web of Science ®Google Scholar
• Shaltout HA, Diz DI, Fortunato JE. Effect of fludrocortisone acetate on nausea and autonomic function during tilt in children with postural orthostatic tachycardia syndrome. Auton Neurosci Basic Clin. 2011;163(1):95. doi:10.1016/j.autneu.2011.05.159
   Google Scholar
• Ross AJ, Ocon AJ, Medow MS, Stewart JM. A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome. Clin Sci Lond Engl. 2014;126(4):289–296. doi:10.1042/CS20130222
   PubMed Web of Science ®Google Scholar
• Rodriguez B, Hoepner R, Salmen A, Kamber N, Z’Graggen WJ. Immunomodulatory treatment in postural tachycardia syndrome: a case series. Eur J Neurol. 2021;28(5):1692–1697. doi:10.1111/ene.14711
   PubMed Web of Science ®Google Scholar